Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 19, 2023
Benzodiazepine analysis by an improved LC-MS/MS method illustrates usage patterns in Washington State
Ka Keung Chan, Andrea J Moore, Andrew N Hoofnagle, et al.
Journal of Analytical Toxicology
|
August 9, 2023
Pastry precautions: Poppy seed-containing products cause significant positive results in urine drug tests
Rebecca J Wilson, Thomas J Laha, Geoffrey S Baird, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 28, 2016
Precision Medicine Starts With Preanalytics: Real-Time Assessment of Tissue Fixation Quality by Ultrasound Time-of-Flight Analysis
Melissa L Lerch, Daniel R Bauer, David Chafin, et al.
Clinical Biochemistry
|
August 23, 2015
Challenges in harmonizing integrated healthcare network laboratories: multi-center evaluation of the hCG5 assay
Dina N Greene, Geoffrey S Baird, Shiu-Land Kwong, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 10, 2022
A Second-generation opioid LC-MS/MS assay improves laboratory workflow and capacity
Hsuan-Chieh Liao, Thomas J Laha, Geoffrey S Baird, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 10, 2024
Clinical implications of opioid parent-metabolite ratios
Hsuan-Chieh Liao, William S Phipps, Michael W Keebaugh, et al.
Clinical Chemistry
|
August 9, 2008
Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry
Luke C Marney, Thomas J Laha, Geoffrey S Baird, et al.
The American Journal of Medicine
|
July 14, 2019
The Reply
Gabrielle N Winston-McPherson, Sheng-Ying Lo, Geoffrey S Baird, et al.
Therapeutic Drug Monitoring
|
December 14, 2020
The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
Jeremy J Day-Storms, Erin M Kren, Jason Bush, et al.
Nature Reviews. Clinical Oncology
|
November 30, 2018
Clinical potential of mass spectrometry-based proteogenomics
Bing Zhang, Jeffrey R Whiteaker, Andrew N Hoofnagle, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 19, 2023
Benzodiazepine analysis by an improved LC-MS/MS method illustrates usage patterns in Washington State
Ka Keung Chan, Andrea J Moore, Andrew N Hoofnagle, et al.
Journal of Analytical Toxicology
|
August 9, 2023
Pastry precautions: Poppy seed-containing products cause significant positive results in urine drug tests
Rebecca J Wilson, Thomas J Laha, Geoffrey S Baird, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
December 28, 2016
Precision Medicine Starts With Preanalytics: Real-Time Assessment of Tissue Fixation Quality by Ultrasound Time-of-Flight Analysis
Melissa L Lerch, Daniel R Bauer, David Chafin, et al.
Clinical Biochemistry
|
August 23, 2015
Challenges in harmonizing integrated healthcare network laboratories: multi-center evaluation of the hCG5 assay
Dina N Greene, Geoffrey S Baird, Shiu-Land Kwong, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
September 10, 2022
A Second-generation opioid LC-MS/MS assay improves laboratory workflow and capacity
Hsuan-Chieh Liao, Thomas J Laha, Geoffrey S Baird, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
October 10, 2024
Clinical implications of opioid parent-metabolite ratios
Hsuan-Chieh Liao, William S Phipps, Michael W Keebaugh, et al.
Clinical Chemistry
|
August 9, 2008
Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry
Luke C Marney, Thomas J Laha, Geoffrey S Baird, et al.
The American Journal of Medicine
|
July 14, 2019
The Reply
Gabrielle N Winston-McPherson, Sheng-Ying Lo, Geoffrey S Baird, et al.
Therapeutic Drug Monitoring
|
December 14, 2020
The Hidden Cost of the Opioid Epidemic in the United States: Drug Screening in Insurance Claims
Jeremy J Day-Storms, Erin M Kren, Jason Bush, et al.
Nature Reviews. Clinical Oncology
|
November 30, 2018
Clinical potential of mass spectrometry-based proteogenomics
Bing Zhang, Jeffrey R Whiteaker, Andrew N Hoofnagle, et al.
Page
of 7